One clinical trial faltered on a minor proposed drug, out of a whole fat pipeline with several other candidates nearing the finish line...And you holler, "The sky is falling"...piff.
5 Million is pocket change measured against the cost of winning FDA approval.
If they take their half of the development cost out of our share total, then they are paying almost nothing. We could sell equity to cover that cost as well .
Other than the right of first negotiation, what are they exacting?
If, in the end, the drug is successful ( all the risk is ours functionally and the outlay will be enormous), and if their mfg and marketing offer is decent...Then it might be OK.
But that's a lot of "ifs".
This is not a very appealing deal.
If only 1 in 10 drugs that enter clinical trials succeeds,
and you look at the fat and very promising pipeline..and you check out the solid science...well.
You do the math.
Having been burned by Chinese stocks several times, i sold all of mine.
Fussy stuff like fiduciary duty and loyalty to stockholders seem almost nonexistent and certainly unenforceable
We don't appreciate how much the SEC and the like protect us here in the US and EU.
Rbt; Not my area of expertise, but i know that my solar powered friends who use DC suffer terrific line losses over distance and must use massive copper conductors.
RE batteries as an investment. It appears that battery tech is in real turmoil and rapid developmental change.I don't know how one could chose with any confidence.
Last...Weight on the wheel, unsuspended weight ,is problematic for ride quality.
Look at the pipeline and it's potential! If just a few of the many promising drugs get approval, it's fat city. Yes, it'll take a few years but it's a very good bet.
Chances are excellent this is the best price you will see. Do your DD fast!
You day traders can't see past the end of your noses.
I just bought a lot and will profit very nicely in the long run.
We may never see it much cheaper.
Buy low, sell high...This is low.
Important indeed! Note that there are a bunch of HER2 clinical trials already in progress.
This looks to be a real biggie!
HER2 is expressed in a whole range of nasty cancers, and while a lot of companies are working hard on it and there are a number of clinical trials in process, it's probable that it'll prove necessary to use multiple vaccines at once to cure it.
Huge, well developed pipeline, many partners. Wild market over reaction..Sweet buying opportunity.
Wild market over reaction. This is a minor drug and we can easily afford to shrug it off, but it's hardly dead yet.
I doubled down at 21!...A gift!